Investing in Innovation
Research at the UMass Cancer Center is leading to the development of new anti-cancer drugs and therapeutic strategies for treating a variety of malignancies including breast, ovarian, colon, leukemia, lung, prostate cancer and more.
Partner with UMass Chan Medical School and gain early access to a diversity of innovations available for licensing, world-renowned research expertise, start-up opportunities, investment opportunities, and opportunities to support our activities.
The Office of Business Development & Innovation (BD&I) and the Office of Technology Management (OTM) serves as the hub of all commercialization activities at UMass Chan Medical School. It facilitates intellectual property protection, business opportunity development, technology licensing, and new-enterprise creation.